Literature DB >> 1938356

Glottic cancer involving anterior commissure: surgery vs radiotherapy.

L Rucci1, O Gallo, O Fini-Storchi.   

Abstract

A retrospective review of 182 patients with glottic cancer involving the anterior commissure (AC) is presented. Of these, 123 patients were first treated with conservative surgery and 59 underwent radiotherapy. Patients were staged according to the AJCC system and by the modality of neoplastic involvement of AC (pure AC cancer, glottic cancer involving AC up to the midline, and beyond the midline). Our results indicate a higher rate of local control and of specific-disease survival in the group of patients first treated with surgery than those treated with radiotherapy (86% vs 74% and 97.5% vs 84%, respectively) (p less than 0.05). For pure AC cancers, our results show better local control with primary radiotherapy than with conservation surgery (82% vs 76.5%), but surgical failures have been more successfully salvaged than have radiotherapy recurrences (ultimate local control, 97.5% vs 82%, respectively). These data suggest that the treatment of choice for AC cancers is conservation surgery, particularly frontolateral laryngectomy.

Entities:  

Mesh:

Year:  1991        PMID: 1938356     DOI: 10.1002/hed.2880130505

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  9 in total

1.  Prognostic evaluation in supracricoid partial laryngectomy with cricohyoidopexy.

Authors:  Lorenza Targa; Enrico Grandi; Giulia Chiarello; Antonio Farina; Francesco Carinci; Roberto Merlo; Antonio Pastore
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-11-12       Impact factor: 2.503

2.  Hyperfractionated radiotherapy for T2 glottic cancer for preservation of the larynx.

Authors:  Ichiro Tateya; Shigeru Hirano; Hisayoshi Kojima; Koichi Omori; Kazuhiko Shoji; Michihide Mitsumori; Yasushi Nagata; Juichi Ito
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-07-13       Impact factor: 2.503

3.  Diagnosis of anterior commissure invasion in laryngeal cancer.

Authors:  Baris Naiboglu; Vefa Kinis; Sema Zer Toros; Tulay Erden Habesoglu; Ildem Deveci; Mehmet Surmeli; Erol Egeli
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-13       Impact factor: 2.503

Review 4.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

5.  The incidence of thyroid cartilage invasion through the anterior commissure in clinically early-staged laryngeal cancer.

Authors:  Murat Ulusan; Selin Unsaler; Bora Basaran; Dilek Yılmazbayhan; Ismet Aslan
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-17       Impact factor: 2.503

6.  The "gregorio marañon" hospital experience in the treatment of laryngeal carcinoma.

Authors:  M F Vega; T Martinez; B Scola; E Scola; S F Vega
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1997-07

7.  Traditional transcutaneous approaches in head and neck surgery.

Authors:  Ulrich R Goessler
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

8.  Prognostic factors in the treatment of squamous cell carcinoma of the larynx: partial surgery x radical surgery.

Authors:  Maria da Graça Caminha Vidal; Onivaldo Cervantes; Marcio Abrah Ão; Flávio Carneiro Hojaij; Ali Amar
Journal:  Braz J Otorhinolaryngol       Date:  2007 Nov-Dec

9.  Partial laryngectomy in glottic cancer: complications and oncological results.

Authors:  Agnaldo José Graciano; Marina Sonagli; Ana Gabriela Clemente da Silva; Carlos Augusto Fischer; Carlos Takahiro Chone
Journal:  Braz J Otorhinolaryngol       Date:  2015-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.